InvestorsHub Logo
Followers 2
Posts 81
Boards Moderated 0
Alias Born 04/15/2014

Re: Daktari post# 18473

Sunday, 11/30/2014 8:52:05 AM

Sunday, November 30, 2014 8:52:05 AM

Post# of 140474
I work in a teaching hospital that can and does run 2 Davinci rooms at the same time. Although I am in no way promoting any product over another I hardly consider this Kool-Aid. Do you really think ISRG is deaf to constructive criticism from good surgeons like yourself regarding the retraction issue you pointed out? They are a proven corporate behemoth who won't sit around waiting for TITAN's next move. This is big business.

I believe in SPORT and Ximedica but have doubts about TITAN management as I have said. They could have put SPORT out on the market as we were lead to believe and also meet their new timelines with subsequent add-ons necessary for different types of surgery. From a business perspective they now cannot afford another hiccup IMHO without additional significant investor scrutiny.

ISRG's business model is a fact not speculation on my part. What is also a fact to the best of my knowledge is that TITAN has no institutional money invested to date, no finalized product, or any market share. By their own account they are at least 2 years away with others both known and unknown looming on the horizon. One can only hope for under promising with subsequent early roll out of a significant product but considering TITAN's history that appears to be Kool-Aid until proven otherwise.